1. Lupus Foundation of America. Lupus facts and statistics: How common is lupus and who does it affect? Washington, DC: Lupus Foundation of America; 2021.

  2. Kasper DL, Braunwald E, Hauser S. Harrison’s Principles of Internal Medicine. 16th ed. McGraw-Hill Professional; 2004.

  3. Brinks R, Hoyer A, Weber S, et al. Age-specific and sex-specific incidence of systemic lupus erythematosus: An estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002. Lupus Sci Med. 2016; 3 (1): e000181.

  4. Mallavarapu RK, Grimsley EW. The history of lupus erythematosus.South Med J. 2007; 100 (9): 896-898.

  5. Uribe AG, Vilá LM, McGwin G Jr, et al. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004; 31 (10): 1934-1940.

  6. Ponticelli C, Moroni G. Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf. 2017; 16 (3): 411-419.

  7. Kasturi S, Sammaritano LR. Corticosteroids in Lupus. Rheum DisClin North Am. 2016; 42 (1): 47-62, viii.

  8. Kementerian Kesehatan Republik Indonesia. Situasi Lupus di Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia; 2013.

  9. Fatoye F, Gebrye T, Mbada C. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: A systematic review and meta-analysis. Rheumatol Int. 2022; 42 (12): 2097-2107.

  10. Mok MY, Li WL. Do Asian patients have worse lupus? Lupus. 2010;19 (12): 1384-1390.

  11. Ward MM. Education level and mortality in systemic lupus erythematosus (SLE): Evidence of under ascertainment of deaths due to SLE in ethnic minorities with low education levels. ArthritisRheum. 2004; 51 (4): 616-624.

  12. Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: Diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol. 2017; 28 (1): 4-12.

  13. Crampton SP, Morawski PA, Bolland S. Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus. Dis Model Mech. 2014; 7 (9): 1033-1046.

  14. Al-Motwee S, Jawdat D, Jehani GS, et al. Association of HLA-DRB1*15 and HLADQB1*06 with SLE in Saudis. Ann Saudi Med.2013; 33 (3): 229-234.

  15. Azizah MR, Ainol SS, Kong NC, et al. HLA antigens in Malay patients with systemic lupus erythematosus: Association with clinical and autoantibody expression. Korean J Intern Med. 2001; 16 (2): 123-q31.

  16. Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: Clues from genetic and cytokine studies. Clin Rev Allergy Immunol. 2011; 40 (1): 42-49.

  17. Brinks R, Fischer-Betz R, Sander O, et al. Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030. Lupus. 2014; 23 (13): 1407-1411.

  18. Ståhl-Hallengren C, Jönsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000; 27 (3): 685-691.

  19. Ohta A, Nagai M, Nishina M, et al. Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/derma to myositis, and systemic sclerosis in Japan. Mod Rheumatol. 2013; 23 (4): 759-764.

  20. Zen M, Bassi N, Nalotto L, et al. Disease activity patterns in a monocentric cohort of SLE patients: A seven-year follow-up study. Clin Exp Rheumatol. 2012; 30 (6): 856-863.

  21. Conti F, Ceccarelli F, Perricone C, et al. Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: A 2-year follow-up study. PLoS One. 2012; 7(9): e45934.

  22. Voulgarelis M, Kokori SI, Ioannidis JP, et al. Anaemia in systemic lupus erythematosus: Aetiological profile and the role of erythropoietin. Ann Rheum Dis. 2000; 59 (3): 217-222.

  23. Djulbegovic B. Autoimmune hemolytic anemia (Coombs’positive). In: Reasoning and decision making in hematology. New York: Churchill Livingstone; 1992. 51–6 p.

  24. Kementerian Kesehatan Republik Indonesia. Pedoman Pencegahan dan Penanggulangan Anemia pada Remaja Putri dan Wanita Usia Subur (WUS). Jakarta: Kementerian Kesehatan Republik Indonesia; 2018.

  25. Niu Z, Zhang P, Tong Y. Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: A meta-analysis. Int J RheumDis. 2015; 18 (1): 17-28.

  26. Williams TM. Human leukocyte antigen gene polymorphism and the histocompatibility laboratory. J Mol Diagn. 2001; 3 (3): 98-104.

  27. Alcina A, Abad-Grau Mdel M, Fedetz M, et al. Multiple sclerosis riskvariant HLA-DRB1*1501 associates with high expression of DRB1gene in different human populations. PLoS One. 2012; 7 (1): e29819.